The Humberside and North Lincolnshire Haematology Multidisciplinary Team Meeting serves a population of 927,000 derived from the East Riding of Yorkshire, Hull, North Lincolnshire and North East Lincolnshire Clinical Commissioning Groups. The care of patients with haematological malignancies from the following hospitals are discussed in this meeting:
- Diana Princess of Wales (DPW, Grimsby), part of Northern Lincolnshire and Goole Hospitals NHS Foundation Trust (NLAG).
- Hull University Teaching Hospitals NHS Trust (HEYNHST).
- Scunthorpe General Hospital (SGH), part of Northern Lincolnshire and Goole Hospitals NHS Foundation Trust (NLAG).
Purpose and Function of the MDT
The aim of the MDT is to ensure a coordinated approach to diagnosis, treatment and care for all patients with a diagnosis of a haematological cancer. It is committed to achieving the highest standards of care and patient outcomes. Key functions include:
- To review all newly diagnosed haematological cancer patients.
- To facilitate clinical, radiological and pathological correlation.
- To establish and confirm the diagnosis and consider potential therapies.
- To provide comprehensive information to patients and their relatives.
- To agree an initial treatment plan taking into account all clinical information and a holistic assessment of the patient’s needs.
To provide ongoing review as required throughout the patient pathway including review and discussion where a decision to discontinue active cancer therapy is needed.
Guidelines and Pathways
- Acute Myeloid Leukaemia
- Chronic Lymphocytic Leukaemia
- Chronic Myeloid Leukaemia
- Diffuse Large B-cell Lymphoma
- Follicular Lymphoma
- Hodgkin Lymphoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- T-Cell Lymphoma